Idarucizumab for dabigatran reversal in patients with atrial fibrillation undergoing emergency surgery for acute aortic syndrome - Mazur, P; Darocha, T; Filip, G; Grudzień, G; Drwiła, R; Kapelak, B (Pol Arch Intern Med, 2016)
(7–8):